| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/23/2007 | CA2642241A1 New stable hyperbaric composition comprising prilocaine hcl, use of said new composition for intrathecal anaesthesia, and method for manufacturing said composition |
| 08/23/2007 | CA2642239A1 Drug combinations for the treatment of respiratory tract diseases |
| 08/23/2007 | CA2642232A1 Mandelic hydrazides |
| 08/23/2007 | CA2642220A1 Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated diseases or conditions |
| 08/23/2007 | CA2642212A1 Novel tricyclic dihydropyrazines as potassium channel openers |
| 08/23/2007 | CA2642205A1 Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators |
| 08/23/2007 | CA2642152A1 Compositions and methods for oligonucleotide formulations |
| 08/23/2007 | CA2642081A1 Use of 5h-dibenz/b,f/azepine-5-carboxamide derivatives in the treatment of neuropathic pain and neurological disorders |
| 08/23/2007 | CA2641950A1 All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization |
| 08/23/2007 | CA2641933A1 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 08/23/2007 | CA2641917A1 Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin |
| 08/23/2007 | CA2641916A1 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 08/23/2007 | CA2641913A1 1-phenethylpiperidine derivatives and their use as opioid receptor ligands |
| 08/23/2007 | CA2641912A1 Substituted prolinamides, their preparation and their use as pharmaceuticals |
| 08/23/2007 | CA2641776A1 Pyrazoloquinolones are potent parp inhibitors |
| 08/23/2007 | CA2641767A1 Novel diazabicycloalkane derivatives and their medical use |
| 08/23/2007 | CA2641766A1 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 08/23/2007 | CA2641734A1 Acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 08/23/2007 | CA2641673A1 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 08/23/2007 | CA2641616A1 Pharmaceutical formulations |
| 08/23/2007 | CA2641605A1 Pharmaceutical formulations |
| 08/23/2007 | CA2641604A1 Pharmaceutical formulations |
| 08/23/2007 | CA2641441A1 Pyrazoles for the treatment of obesity and other cns disorders |
| 08/23/2007 | CA2641389A1 Hetero-bycyclic antiviral compounds |
| 08/23/2007 | CA2641384A1 Ibandronate regimen for treating metastatic bone pain |
| 08/23/2007 | CA2641382A1 Heterocyclic antiviral compounds |
| 08/23/2007 | CA2641254A1 Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases |
| 08/23/2007 | CA2641216A1 Fixed-dose association of phytate and zinc |
| 08/23/2007 | CA2641106A1 Skin-whitening cosmetic |
| 08/23/2007 | CA2640807A1 Benzoyl-piperidine derivatives as 5ht2/d3 modulators |
| 08/23/2007 | CA2640672A1 3 -deazapurine derivatives as tlr7 modulators |
| 08/23/2007 | CA2640582A1 Pyridine-2-, pyrimidine-2-carboxamide derivatives |
| 08/23/2007 | CA2640304A1 Sulfonamide derivatives for the treatment of bacterial infections |
| 08/23/2007 | CA2640283A1 High dosage of mycophenolic acid (mpa) |
| 08/23/2007 | CA2638847A1 Mcp-i binding nucleic acids |
| 08/23/2007 | CA2638823A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 08/23/2007 | CA2638787A1 Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension |
| 08/23/2007 | CA2637884A1 Compounds for the treatment of metabolic disorders |
| 08/23/2007 | CA2636873A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 08/23/2007 | CA2636617A1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
| 08/23/2007 | CA2636605A1 Novel azacycly-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments |
| 08/23/2007 | CA2635838A1 Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture |
| 08/23/2007 | CA2635205A1 Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives |
| 08/23/2007 | CA2633588A1 Methods of transdermally administering an indole serotonin receptor agonist and transdermal compositions for use in the same |
| 08/23/2007 | CA2631971A1 One pot synthesis of tetrazole derivatives of sirolimus |
| 08/23/2007 | CA2618628A1 Triazole compounds that modulate hsp90 activity |
| 08/23/2007 | CA2560107A1 Nutritional composition and method for increasing creatine uptake and retention in skeletal muscle, increasing muscle mass and strength, increasing exercise capacity and for aiding recovery following exercise |
| 08/23/2007 | CA2556305A1 Rapidly dissolving solid oral dosage form for delivery of composition for increasing nitric oxide activity |
| 08/22/2007 | EP1820854A2 JNK3 modulators and methods of use |
| 08/22/2007 | EP1820805A2 Inhibitor and stimulator of haemotopoietic stem cell proliferation and uses thereof |
| 08/22/2007 | EP1820800A1 Crystalline forms of duloxetine hydrochloride and processes for their preparation |
| 08/22/2007 | EP1820799A1 2,3,4,5-tetrahydro-1h-1,5-benzodiazepine derivative and medicinal composition |
| 08/22/2007 | EP1820798A1 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 08/22/2007 | EP1820797A1 Substituted pyridone derivative |
| 08/22/2007 | EP1820794A1 Method of obtaining cyclic amino acids |
| 08/22/2007 | EP1820515A1 Nitrogen-containing fused ring compound and use thereof |
| 08/22/2007 | EP1820507A1 A pharmaceutical composition for the medical treatment of the benign prostatic hyperplasia, its preparation method and its therapeutical application |
| 08/22/2007 | EP1820506A1 Dipyridamole extended-release formulations and process for preparing same |
| 08/22/2007 | EP1820505A1 Analgesic |
| 08/22/2007 | EP1820504A1 Imine compound |
| 08/22/2007 | EP1820503A2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 08/22/2007 | EP1820502A1 Active substance combination comprising azolylcarbinol compounds |
| 08/22/2007 | EP1820501A1 Therapeutic agent for depletion of an unwanted protein population from plasma |
| 08/22/2007 | EP1820500A1 Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor |
| 08/22/2007 | EP1820499A1 Green algal extract containing astaxanthin having high storage stability |
| 08/22/2007 | EP1820497A2 Effervescent bisphosphonate formulation |
| 08/22/2007 | EP1820496A2 Implant material |
| 08/22/2007 | EP1820495A2 Microspheres for active embolization |
| 08/22/2007 | EP1820494A2 Microspheres of estradiol and cholesterol |
| 08/22/2007 | EP1820442A1 Noninvasive measurements of chemical substances |
| 08/22/2007 | EP1819720A1 A cost-effective process for preparation of manufacture of iron sucrose |
| 08/22/2007 | EP1819713A1 Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic a ivity |
| 08/22/2007 | EP1819712A1 New pyridothienopyrimidine derivatives |
| 08/22/2007 | EP1819710A1 New pyridothienopyrimidine derivatives |
| 08/22/2007 | EP1819709A1 Novel diazabicyclic aryl derivatives as cholinergy ligands |
| 08/22/2007 | EP1819708A2 Substituted pteridines for treating inflammatory diseases |
| 08/22/2007 | EP1819707A2 Substituted pteridines for the treatment of inflammatory diseases |
| 08/22/2007 | EP1819704A1 Pyrrolopyridine-2-carboxylic acid amide derivative useful as inhibitor of glycogen phosphorylase |
| 08/22/2007 | EP1819703A1 Crytalline forms of a pyrazolo `3, 4-c ü pyridine factor xa inhibitor |
| 08/22/2007 | EP1819701A1 Cyclic iminocarbamates and use thereof |
| 08/22/2007 | EP1819700A2 Potassium salt of an hiv intergrase inhibitor |
| 08/22/2007 | EP1819699A2 Diazepine oxazolidinones as antibacterial agents |
| 08/22/2007 | EP1819697A1 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors |
| 08/22/2007 | EP1819696A1 Polymorphic forms of 6-2-(methylcarbamoyl)phenysulfanyl|-3-e-2-(pyridin-2-yl)ethenyl indazole |
| 08/22/2007 | EP1819694A2 SALTS OF N-[2-({3R)-1-[trans-4-HYDROXY-4-(6-METHOXYPYRIDIN-3-YL)-CYCLOHEXYL]PYRROLIDINE-3-YL}AMINO)-2-OXOETHYL]-3-(TRIFLUOROMETHYL)BENZAMIDE |
| 08/22/2007 | EP1819693A1 Antithrombotic diamides |
| 08/22/2007 | EP1819692A1 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators |
| 08/22/2007 | EP1819688A2 Crystalline forms of docetaxel and processes for their preparation |
| 08/22/2007 | EP1819686A1 5-hydroxy-benzothiazole derivatives having beta-2-adrenorecptor agonist activity |
| 08/22/2007 | EP1819684A1 Substituted piperazines as cb1 antagonists |
| 08/22/2007 | EP1819683A2 Potassium salt of an hiv integrase inhibitor |
| 08/22/2007 | EP1819680A1 Bengamides with a substituted caprolactame cycle, method for the preparation thereof, compositions containing them and use thereof |
| 08/22/2007 | EP1819679A2 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof |
| 08/22/2007 | EP1819676A2 5-phenyl-5,6,7,8-hydroquinoline tachykinin receptor antagonists |
| 08/22/2007 | EP1819675A1 5-amino-4-hydroxy-2-isopropyl-7-ý4-methoxy-3-(3-methoxypropxy)benzyl¨-8-methylnonanamides |
| 08/22/2007 | EP1819672A1 Indole-2-carboxylic acid amides |
| 08/22/2007 | EP1819671A2 Hcv inhibitors with carbazole structure |
| 08/22/2007 | EP1819670A1 12-aryl prostaglandin analogs |
| 08/22/2007 | EP1819669A2 Novel inhibitors of histone deacetylase for the treatment of disease |
| 08/22/2007 | EP1819667A1 Sulfonamide compounds as cysteine protease inhibitors |